Press Review (June 30, 2012) – Revue de presse (30 juin 2012)

Women's lung cancer deaths up in South and Midwest‎

Despite falling lung cancer rates across the U.S. in the past decade, researchers report that deaths from the disease are steady or rising among middle-aged women in southern and Midwestern states.

By Natasja Sheriff. In Reuters

http://www.reuters.com/article/2012/06/26/us-women-lungcancer-death-idUSBRE85P1H520120626

Side effects persist after prostate cancer treatment‎‎

Men who are treated for prostate cancer may still suffer side effects from treatment up to a decade later, a new study finds‎.

By Amy Norton. In Reuters

http://www.reuters.com/article/2012/06/27/us-prostratecancer-idUSBRE85Q14320120627

Is it Rationing? Cancer Screening and Clinical Uncertainty‎

Last month, the federal panel that decides which preventive services health plans must cover said it will drop blood testing for prostate cancer. The president of the trade group that represents urologists proclaimed himself and his organization "outraged." He warned that refusal to cover the test, for levels of prostate-specific antigen (PSA), will cost lives. And he played the race card, calling it "inappropriate and irresponsible to issue a blanket statement against PSA testing, particularly for at-risk populations, such as African-American men."

By M. Gregg Bloche. In Huffington Post

http://www.huffingtonpost.com/m-gregg-bloche-md-jd/prostate-cancer-screening_b_1622577.html

EU agency backs Novartis' Afinitor in breast cancer

European regulators on Friday recommended approval of a Novartis' for the treatment of advanced breast cancer.

In Reuters

http://www.reuters.com/article/2012/06/22/us-novartis-afinitor-chmp-idUSBRE85L0K920120622

Glucose deprivation activates feedback loop that kills cancer cells, UCLA study shows

Compared to normal cells, cancer cells have a prodigious appetite for glucose, the result of a shift in cell metabolism known as aerobic glycolysis or the "Warburg effect." Researchers focusing on this effect as a possible target for cancer therapies have examined how biochemical signals present in cancer cells regulate the altered metabolic state.

By Jennifer Marcus. In UC Los Angeles News

http://newsroom.ucla.edu/portal/ucla/researchers-discover-that-glucose-235478.aspx

Moderate exercise tied to lower breast cancer risk: study‎

Women who exercise moderately may be less likely than their inactive peers to develop breast cancer after menopause, according to a U.S. study‎.

In Reuters

http://in.reuters.com/article/2012/06/26/health-cancer-exercise-idINL3E8HQ00220120626

What Is Acute Myelogenous Leukemia, the Cancer That Struck Nora Ephron?

The When Harry Met Sally screenwriter recently succumbed to this enigmatic form of cancer, but there are new treatments in the pipeline.

By Larry Greenemeier. In Scientific American

http://www.scientificamerican.com/article.cfm?id=what-is-acute-myelogenous-leukemia

Cutaneous Human Papillomavirus Infection a Risk Factor for Skin Cancer

Researchers at Moffitt Cancer Center and colleagues at the University of South Florida, the German Cancer Research Center in Heidelberg, and the International Agency for Research on Cancer in Lyon, France, conducted a case control study and found associations between having antibodies to certain types of cutaneous human papillomavirus (HPV) and a kind of skin cancer called squamous cell carcinoma (SCC).

In Newswise

http://www.newswise.com/articles/cutaneous-human-papillomavirus-infection-a-risk-factor-for-skin-cancer

Study identifies pathway to enhance usefulness of EGFR inhibitors in lung cancer treatment

Many lung cancers are driven by mutations in the epidermal growth-factor receptor (EGFR), and so it makes sense that many successful modern treatments block EGFR activity. Unfortunately, cancers inevitably evolve around EGFR inhibition, and patients with lung cancers eventually relapse. A University of Colorado Cancer Center study published today in the journal Cancer Research details a signaling pathway, known as 'the canonical Wnt pathway', that lung cancer cells use to escape from EGFR-targeted therapy – and suggests that by disrupting this pathway, we could lengthen the usefulness of existing EGFR inhibition therapies.

In Medical Xpress

http://medicalxpress.com/news/2012-06-pathway-egfr-inhibitors-lung-cancer.html

Metformin may lower cancer risk in people with Type 2 diabetes‎

‎A commonly prescribed diabetes drug, metformin, reduces the overall cancer risk in people with Type 2 diabetes, a large systematic review study finds. The results to be presented at The Endocrine Society's 94th Annual Meeting in Houston.

In Medical Xpress

http://medicalxpress.com/news/2012-06-metformin-cancer-people-diabetes.html

Les "perles" du cancer‎‎

"T'as acheté bio, ton cancer aussi sera bio. Et, pour la chimio, je te conseille la coccinelle." Cette réplique de Not, le "punk à chien" interprété par Benoît Poelvoorde dans le film Le Grand Soir de Bruno Delépine et Gustave Kerven, m'a fait rire aux éclats et ne me quitte pas. Assis sur le bitume d'un parking de centre commercial, Not interpelle ainsi un couple qui pousse son chariot rempli de produits biologiques. L'histoire ne dit pas si ces consommateurs repartent ensuite en voiture diesel "qui pue et qui pollue" et se grillent une cigarette en arrivant chez eux pour décompresser de leur samedi passé à faire les courses. Le soir, ils se rassureront sur leur hygiène de vie en mangeant du bio.

Par Sandrine Blanchard. Dans Le Monde

http://www.lemonde.fr/idees/article/2012/06/27/les-perles-du-cancer_1725219_3232.html

Diagnostiquer un cancer à partir d'une prise de sang‎

Une équipe française de médecins biologistes travaillant à l’Institut Curie de Paris vient de mettre au point  une technique permettant de détecter de l’ADN d’une tumeur cancéreuse dans le sang du malade. Ce procédé simple, reproductible et peu coûteux pourrait à terme s’appliquer à tous les cancers pour lesquels une mutation génétique a d’ores et déjà été identifiée.

Dans Slate

http://www.slate.fr/lien/58387/cancer-sang-diagnostic

Cancer: un essai pour tenter de généraliser les traitements personnalisés

L'Institut Gustave Roussy (IGR) a annoncé jeudi le lancement d'un essai clinique international pour proposer des traitements personnalisés à des patients qui, jusqu'à présent, ne pouvaient bénéficier que de traitements standards.

"L'objectif de cet essai est de proposer un traitement personnalisé à la très grande majorité des patients" alors qu'actuellement seulement 30% des patients peuvent en bénéficier, indique dans un communiqué l'IGR, établissement privé situé en région parisienne qui se présente comme "premier centre de lutte contre le cancer en Europe".

AFP

http://www.google.com/hostednews/afp/article/ALeqM5iwUGcNNPftltYzWafIzTHBqxEW5Q?docId=CNG.f2cb774c36314f054aed4b0fc22873fc.321

Traiter le cancer comme une maladie chronique‎

De nouvelles recherches pourraient conduire ainsi à des traitements permettant de faire passer le cancer d'une maladie mortelle à une maladie chronique.

Dans bulletins-electroniques.com

http://www.bulletins-electroniques.com/actualites/70402.htm

Hausse des cancers chez les jeunes Algériens

Les adolescents et jeunes adultes âgés entre 15 et 39 ans sont de plus en plus affectés par le cancer. Le cancer du sein touche 30% de cette population. La consanguinité, l’alimentation et l’environnement sont les facteurs les plus incriminés.

Dans El Watan

http://www.elwatan.com/une/hausse-des-cancers-chez-les-jeunes-algeriens-24-06-2012-175962_108.php